BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

189 related articles for article (PubMed ID: 32459721)

  • 21. Haplo-Cord transplantation compared to haploidentical transplantation with post-transplant cyclophosphamide in patients with AML.
    Kwon M; Bautista G; Balsalobre P; Sánchez-Ortega I; Montesinos P; Bermúdez A; de Laiglesia A; Herrera P; Martin C; Humala K; Zabalza A; Torres M; Bento L; Corral LL; Heras I; Serrano D; Buño I; Anguita J; Regidor C; Duarte R; Cabrera R; Gayoso J; Diez-Martin JL
    Bone Marrow Transplant; 2017 Aug; 52(8):1138-1143. PubMed ID: 28346415
    [TBL] [Abstract][Full Text] [Related]  

  • 22. A myeloablative fractionated busulfan conditioning regimen with post-transplant cyclophosphamide in HLA-matched and haploidentical transplantation: results of a phase II study.
    Popat UR; Andersson BS; Bassett R; Kawedia J; Valdez BC; Alousi AM; Al-Atrash G; Bashir Q; Hosing CM; Im JS; Kebriaei P; Marin D; Nieto Y; Oran B; Olson A; Qazilbash MH; Srour SA; Shpall EJ; Champlin RE; Mehta RS
    Haematologica; 2022 Oct; 107(10):2496-2500. PubMed ID: 35770531
    [No Abstract]   [Full Text] [Related]  

  • 23. Clofarabine followed by haploidentical stem cell transplant using fludarabine, busulfan, and total-body irradiation with post-transplant cyclophosphamide in non-remission AML.
    Rakszawski K; Miki K; Claxton D; Wagner H; Shike H; Mineishi S; Naik S
    Int J Hematol; 2018 Sep; 108(3):348-350. PubMed ID: 29542029
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Clinical Utility of the Detection of the Loss of the Mismatched HLA in Relapsed Hematological Patients After Haploidentical Stem Cell Transplantation With High-Dose Cyclophosphamide.
    Muñiz P; Kwon M; Carbonell D; Chicano M; Bailén R; Oarbeascoa G; Suárez-González J; Andrés-Zayas C; Menárguez J; Dorado N; Gómez-Centurión I; Anguita J; Díez-Martín JL; Martínez-Laperche C; Buño I
    Front Immunol; 2021; 12():642087. PubMed ID: 33841425
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Improved Outcome of Refractory/Relapsed Acute Myeloid Leukemia after Post-Transplantation Cyclophosphamide-Based Haploidentical Transplantation with Myeloablative Conditioning and Early Prophylactic Granulocyte Colony-Stimulating Factor-Mobilized Donor Lymphocyte Infusions.
    Jaiswal SR; Zaman S; Chakrabarti A; Sen S; Mukherjee S; Bhargava S; Ray K; O'Donnell PV; Chakrabarti S
    Biol Blood Marrow Transplant; 2016 Oct; 22(10):1867-1873. PubMed ID: 27470289
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Successful haploidentical hematopoietic stem cell transplantation with post-transplant cyclophosphamide in a child with X-linked chronic granulomatous disease: A first report in Asia.
    Janjindamai C; Manuyakorn W; Anurathapan U; Pakakasama S; Wattanasirichaigoon D; Kamchaisatian W; Benjaponpitak S; Hongeng S
    Asian Pac J Allergy Immunol; 2022 Sep; 40(3):278-282. PubMed ID: 31677618
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Successful T replete haploidentical HSCT with post-transplant cyclophosphamide in two patients with Wiskott-Aldrich syndrome.
    Kapoor R; Yanamandra U; Kumar R; Pramanik SK
    Med J Armed Forces India; 2023; 79(6):722-725. PubMed ID: 37981926
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Posttransplant Cyclophosphamide and Antithymocyte Globulin versus Posttransplant Cyclophosphamide as Graft-versus-Host Disease Prophylaxis for Peripheral Blood Stem Cell Haploidentical Transplants: Comparison of T Cell and NK Effector Reconstitution.
    Makanga DR; Guillaume T; Willem C; Legrand N; Gagne K; Cesbron A; Gendzekhadze K; Peterlin P; Garnier A; Le Bourgeois A; Béné MC; Chevallier P; Retière C
    J Immunol; 2020 Sep; 205(5):1441-1448. PubMed ID: 32747504
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Haploidentical stem cell transplantation in a boy with chronic granulomatous disease.
    Regueiro-García A; Fariña-Nogueira S; Porto-Arceo JÁ; Couselo-Sánchez JM
    Allergol Immunopathol (Madr); 2018; 46(4):385-388. PubMed ID: 29373243
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Tandem Orthotopic Living Donor Liver Transplantation Followed by Same Donor Haploidentical Hematopoietic Stem Cell Transplantation for DOCK8 Deficiency.
    Freeman AF; Yazigi N; Shah NN; Kleiner DE; Parta M; Atkinson P; Heller T; Holland SM; Kaufman SS; Khan KM; Hickstein DD
    Transplantation; 2019 Oct; 103(10):2144-2149. PubMed ID: 30720689
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Haploidentical Stem Cell Transplant With Post-transplant Cyclophosphamide for Chediak-Higashi Syndrome: A Very Rare Case Report.
    Sachdev M; Bansal M; Chakraborty S; Hamal S; Bhargava R; Dua V
    J Pediatr Hematol Oncol; 2021 Oct; 43(7):e1030-e1032. PubMed ID: 33093354
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Toward safer haploidnetical hematopoietic stem cell transplantation.
    Sidlik-Muskatel R; Reisner Y
    Bone Marrow Transplant; 2019 Aug; 54(Suppl 2):733-737. PubMed ID: 31431713
    [TBL] [Abstract][Full Text] [Related]  

  • 33. A Comparison of the Myeloablative Conditioning Regimen Fludarabine/Busulfan with Cyclophosphamide/Total Body Irradiation, for Allogeneic Stem Cell Transplantation in the Modern Era: A Cohort Analysis.
    Gooptu M; Kim HT; Ho VT; Alyea EP; Koreth J; Armand P; Ritz J; Nikiforow S; Glotzbecker BE; Nageshwar P; Soiffer RJ; Antin JH; Cutler CS
    Biol Blood Marrow Transplant; 2018 Aug; 24(8):1733-1740. PubMed ID: 29555313
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Haploidentical Hematopoietic Stem Cell Transplantation with Post-Transplant Cyclophosphamide for Primary Immunodeficiencies and Inherited Disorders in Children.
    Neven B; Diana JS; Castelle M; Magnani A; Rosain J; Touzot F; Moreira B; Fremond ML; Briand C; Bendavid M; Levy R; Morelle G; Vincent M; Magrin E; Bourget P; Chatenoud L; Picard C; Fischer A; Moshous D; Blanche S
    Biol Blood Marrow Transplant; 2019 Jul; 25(7):1363-1373. PubMed ID: 30876929
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Lentiviral haemopoietic stem/progenitor cell gene therapy for treatment of Wiskott-Aldrich syndrome: interim results of a non-randomised, open-label, phase 1/2 clinical study.
    Ferrua F; Cicalese MP; Galimberti S; Giannelli S; Dionisio F; Barzaghi F; Migliavacca M; Bernardo ME; Calbi V; Assanelli AA; Facchini M; Fossati C; Albertazzi E; Scaramuzza S; Brigida I; Scala S; Basso-Ricci L; Pajno R; Casiraghi M; Canarutto D; Salerio FA; Albert MH; Bartoli A; Wolf HM; Fiori R; Silvani P; Gattillo S; Villa A; Biasco L; Dott C; Culme-Seymour EJ; van Rossem K; Atkinson G; Valsecchi MG; Roncarolo MG; Ciceri F; Naldini L; Aiuti A
    Lancet Haematol; 2019 May; 6(5):e239-e253. PubMed ID: 30981783
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Successful Myeloablative Matched Unrelated Donor Hematopoietic Stem Cell Transplantation in a Young Girl With GATA2 Deficiency and Emberger Syndrome.
    Ramzan M; Lowry J; Courtney S; Krueger J; Schechter Finkelstein T; Ali M
    J Pediatr Hematol Oncol; 2017 Apr; 39(3):230-232. PubMed ID: 28234738
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Haploidentical transplant with posttransplant cyclophosphamide vs matched unrelated donor transplant for acute myeloid leukemia.
    Ciurea SO; Zhang MJ; Bacigalupo AA; Bashey A; Appelbaum FR; Aljitawi OS; Armand P; Antin JH; Chen J; Devine SM; Fowler DH; Luznik L; Nakamura R; O'Donnell PV; Perales MA; Pingali SR; Porter DL; Riches MR; Ringdén OT; Rocha V; Vij R; Weisdorf DJ; Champlin RE; Horowitz MM; Fuchs EJ; Eapen M
    Blood; 2015 Aug; 126(8):1033-40. PubMed ID: 26130705
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Haploidentical Related Donor Hematopoietic Stem Cell Transplantation for Dedicator-of-Cytokinesis 8 Deficiency Using Post-Transplantation Cyclophosphamide.
    Shah NN; Freeman AF; Su H; Cole K; Parta M; Moutsopoulos NM; Baris S; Karakoc-Aydiner E; Hughes TE; Kong HH; Holland SM; Hickstein DD
    Biol Blood Marrow Transplant; 2017 Jun; 23(6):980-990. PubMed ID: 28288951
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Successful engraftment of haploidentical bone marrow with post-transplantation cyclophosphamide in patients with aplastic anemia.
    Dang BN; De Oliveira S; Gray A; Bowles L; Moore TB
    Pediatr Transplant; 2020 Mar; 24(2):e13652. PubMed ID: 31944531
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Haploidentical bone marrow transplantation with post transplant cyclophosphamide for patients with X-linked adrenoleukodystrophy: a suitable choice in an urgent situation.
    Fernandes JF; Bonfim C; Kerbauy FR; Rodrigues M; Esteves I; Silva NH; Azambuja AP; Mantovani LF; Kutner JM; Loth G; Kuwahara CC; Bueno C; Kondo AT; Ribeiro AAF; Kok F; Hamerschlak N
    Bone Marrow Transplant; 2018 Apr; 53(4):392-399. PubMed ID: 29330393
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.